Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
2024 Standout
Works of Florence Atrafi being referenced
A phase I dose-finding and pharmacokinetics study of CPC634 (nanoparticle entrapped docetaxel) in patients with advanced solid tumors.
2019
Phase 1/2 study of veliparib (V) combined with carboplatin (Cb) and etoposide (E) in patients (pts) with extensive-stage disease (ED) small cell lung cancer (SCLC) and other solid tumors: Phase 1 results.
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Florence Atrafi | 99 | 13 | 101 | 113 | 17 | 310 | |
| Shaomin Che | 108 | 3 | 147 | 63 | 17 | 339 | |
| Ziping Sun | 64 | 6 | 116 | 39 | 23 | 302 | |
| Kun Mi | 111 | 5 | 144 | 50 | 17 | 327 | |
| María Loreto Bravo | 114 | 18 | 114 | 104 | 21 | 357 | |
| Yun‐Long Tseng | 97 | 4 | 181 | 163 | 14 | 346 | |
| Komal Mandleywala | 113 | 4 | 102 | 47 | 15 | 331 | |
| Ladislav Sivák | 105 | 3 | 107 | 131 | 21 | 330 | |
| Justyna Czapla | 92 | 79 | 130 | 44 | 21 | 333 | |
| Hye-Yeong Kim | 64 | 9 | 91 | 48 | 15 | 350 | |
| Hao‐Hao Wang | 71 | 24 | 123 | 69 | 18 | 318 |
All Works
Login with ORCID to disown or claim papers
Loading papers...